Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US3847471014
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG01N6CGW43
GRAL
Grail, Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $HLTH
NAME
Grail, Inc.
ISIN
US3847471014
TICKER
GRAL
MIC
XNAS
REUTERS
GRAL.OQ
BLOOMBERG
GRAL US
Di., 23.09.2025       Grail Inc.
US3847471014

First PATHFINDER 2 Results Accepted as a Late-Breaking Presentation at the European Society for Medical Oncology (ESMO) Congress 2025; Results to be Submitted to FDA as Part of the Galleri Premarket Approval Application (PMA) Updated SYMPLIFY and REFLECTION Study Results to be Presented at the Early Detection of Cancer Conference (EDCC) Highligh...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 10.09.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Sept. 10, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual Healthcare Forum on Wednesday, Sep. 24 at 8:00 a.m. ET. ...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 26.08.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Aug. 26, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sep. 9 at 1:50 p.m. ET. ...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 12.08.2025       Grail Inc.
US3847471014

Q2 U.S. Galleri Revenue Grew 21% Year-Over-Year to $34.2 Million Q2 Galleri Tests Sold Grew 29% Year-Over-Year to More Than 45,000 Detailed Results From First 25,000 Enrolled in PATHFINDER 2 to be Submitted for Presentation at ESMO 2025 in October MENLO PARK, Calif., Aug. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company w...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 30.07.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., July 30, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity 45th Annual Growth Conference in Boston on Wednesday, Aug. 13 at 8:30 a.m. ET. ...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 29.07.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., July 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the second quarter 2025 following the close of market on Tuesday, Aug. 12, 2025. Following the release, company management will ho...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 18.06.2025       Grail Inc.
US3847471014

Cancer Detection and Positive Predictive Value Substantially Higher Than the Previously Published PATHFINDER Study MENLO PARK, Calif., June 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced positive top-line performance and safety results from th...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Fr., 30.05.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., May 30, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 77,350 shares of GRAIL's common stock to 38 recently hired non-e...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 21.05.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., May 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Jefferies Global Healthcare Conference 2025 in New York on Tuesday, June 4 at 11:40 a.m. ET. ...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 13.05.2025       Grail Inc.
US3847471014

Q1 U.S. Galleri Revenue Grew 22% Year-Over-Year to $28.7 Million GRAIL Announces Positive Top-Line Results From the Prevalent Screening Round of the NHS-Galleri Trial Cash Position of $677.9 Million Provides Runway Into 2028 MENLO PARK, Calif., May 13, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detec...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 12.05.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a new partnership with athenahealth, a leading provider of network-enabled software and services for healthcare practices and systems nationwide. This collaboration will in...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 29.04.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., April 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the first quarter 2025 following the close of market on Tuesday, May 13, 2025. Following the release, company management will hos...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 22.04.2025       Grail Inc.
US3847471014

Real-World Data in 100,000 Patients Further Support the Galleri® Test's Ability to Simultaneously Screen for Multiple Cancers, as Well as its Accuracy of Cancer Signal of Origin Prediction to Support More Efficient Diagnostic Evaluations Data From GRAIL's ctDNA-based Targeted Methylation Assay Highlight Potential to Identify Robust Signals of Pr...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 26.02.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Feb. 26, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 108,450 shares of GRAIL's common stock to 15 recently hired non...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 25.02.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Feb. 25, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, has partnered with award-winning actress Kate Walsh to launch Generation Possible, an educational initiative to raise awareness of multi-cancer early detection (MCED) testing. Generation P...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Fr., 21.02.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday, Mar. 4 at 9:10 a.m. ET. ...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Do., 20.02.2025       Grail Inc.
US3847471014

Sold More than 137,000 Galleri® Tests in 2024, Growing U.S. Galleri Revenue 45% Year-Over-Year to $108.6 Million Completed Study Visits for Two Registrational Studies in July to Support Modular PMA Submission for Galleri On Track for Continued Commercial Growth in 2025 with TRICARE Coverage and Recent Announcement of Quest Integration Moderated...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 12.02.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Feb. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter 2024 following the close of market on Thursday, Feb. 20, 2025. Following the release, company management will h...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 12.02.2025       Grail Inc.
US3847471014

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience  MENLO PARK, Calif. and SECAUCUS, N.J., Feb. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 14.01.2025       Grail Inc.
US3847471014

Analysis of Patient Reported Outcomes From PATHFINDER Indicate Minimal Patient Distress Associated with Multi-Cancer Early Detection Testing MENLO PARK, Calif., Jan. 13, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that patient-reported outcomes...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 18.12.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Dec. 18, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15 at 9:00 a.m. PT. ...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 03.12.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Dec. 3, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 115,093 shares of GRAIL's common stock to 46 recently hired non-...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 19.11.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will participate in the following investor conferences....
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mo., 18.11.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Nov. 18, 2024  /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the first patient has been tested for eligibility with the investigational GRAIL Non-Small Cell Lung Cancer (NSCLC) ctDNA Assay in the global TROPION-Lung12 Phase 3...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 12.11.2024       Grail Inc.
US3847471014

Galleri Revenue Grew 52% Year-Over-Year to $25.4 Million Commercial Galleri Sales Surpassed 250,000 Tests Since Launch Cash Balance of $853.6 Million Provides Runway Into 2028 MENLO PARK, Calif., Nov. 12, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today repor...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mo., 04.11.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Nov. 4, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 29.10.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Oct. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2024 following the close of market on Tuesday, Nov. 12, 2024. Following the release, company management will hos...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Do., 24.10.2024       Grail Inc.
US3847471014

Study Participants from Veteran Affairs Sites Include a Diverse Population With Toxic Exposure MENLO PARK, Calif., Oct. 23, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced early results from the REFLECTION study, which aims to understand the real-...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mo., 21.10.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Oct. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the appointment of Sarah Krevans to its Board of Directors, effective immediately. Ms. Krevans will also serve as a member of the Board's Audit Committee, Compensation Com...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Fr., 30.08.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Aug. 30, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 182,223 shares of GRAIL's common stock to 55 recently hired non-e...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Do., 29.08.2024       Grail Inc.
US3847471014

Data Support Clinical Performance of Galleri to Detect More Aggressive Prostate Cancers MENLO PARK, Calif., Aug. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings of the performance of its Galleri® multi-cancer early detect...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 21.08.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Aug. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 3:20 p.m. ET on Sept. 4, 2024....
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Di., 13.08.2024       Grail Inc.
US3847471014

Second Quarter Revenue Grew 43% Year-Over-Year to $32.0 Million Portfolio Prioritization and Corporate Restructure Extends Cash Runway into 2028 MENLO PARK, Calif., Aug. 13, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial resu...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Do., 08.08.2024       Grail Inc.
US3847471014

Veteran Leader Brings Deep Strategic, Aviation, and Governance Experience to Boardroom ATLANTA, Aug. 8, 2024 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE: UP) today announced that Gregory L. Summe, Managing Partner of Glen Capital Partners LLC, joined its Board of Directors, effective August 7....
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink
Mi., 10.07.2024       Grail Inc.
US3847471014

Das Instrument NL0 US3847471014 GRAIL INC. DL-,01 EQUITY hat seinen ersten Handelstag am 11.07.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument NL0 US3847471014 GRAIL INC. DL-,01 EQUITY has its first trading date on 11.07.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...
Zur Nachricht
Grail Inc.
Charts & Research Termsheets Terminal
Permalink